Latest revenue
$2.2M
as of 2026-03-31
Latest net income
$-839.9K
as of 2026-03-31
Net margin
-38.8%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $33.7M
- Enterprise value
- $33.7M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $1.01
- 52-wk low
- $0.22
- Beta
- —
- Shares out
- 88.1M
5-year trend
What this company does
Item 1. Business Overview Milestone Scientific Inc. was incorporated in the State of Delaware in August 1989. The Company develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The Company’s core technology platform, Dynamic Pressure Sensing® (“DPS”) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the Company’s dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional…
AI summary unavailable — showing raw filing excerpt
Generated from MLSS's filing dated 2026-03-31
Key risks
Item 1A. Risk Factors You should carefully consider the risks and uncertainties described below, together with the other information included in this Annual Report on Form 10-K. If any of the risks described below occur, our business, financial condition, results of operations, and prospects could be materially and adversely affected. The risks described below are not the only risks we face. Additional risks and uncertainties that we do not currently know about, or that we currently believe are immaterial, also may materially and adversely affect our business, financial condition, results of operations, and/or prospects. These disclosures reflect the Company’s beliefs and opinions as to…
AI summary unavailable — showing raw filing excerpt
Generated from MLSS's filing dated 2026-03-31
Profitability
Gross margin
71.4%
4.2%Operating margin
-63.5%
18.9%Net margin
-63.8%
16.7%Return on equity
-203.4%
151.8%Return on assets
-73.3%
52.4%Leverage
Debt / equity
1.78×
161.2%Long-term debt / equity
0.28×
2934.5%Debt / assets
64.0%
58.1%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $2.2M | -3.2% | $-839.9K | +57.9% | -38.8% |
Q4 2025 2025-12-31 | $2.1M | +2.2% | — | — | — |
Q3 2025 2025-09-30 | $2.4M | -6.1% | $-1.2M | +21.0% | -48.9% |
Q2 2025 2025-06-30 | $2.3M | +25.3% | — | — | — |
Q1 2025 2025-03-31 | $2.2M | -0.7% | $-2.0M | -38.5% | -89.3% |
Q4 2024 2024-12-31 | $2.0M | — | $-2.0M | — | -101.1% |
Q3 2024 2024-09-30 | $2.5M | +22.1% | $-1.5M | +0.3% | -58.1% |
Q2 2024 2024-06-30 | $1.9M | -36.3% | $223.6K | +110.1% | 12.1% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842
Your notes
Keep private notes on MLSS — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$471.7K
Net activity
−$471.7K
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns MLSS
Institutional value
$918.5K
Total shares held
3.2M
Distinct holders
21
-10 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $572.2K | — | New |
| 2 | VANGUARD FIDUCIARY TRUST CO | 321.6K | $92.6K | — | New |
| 3 | LPL Financial LLC | 124.9K | $36.0K | +20.0K (+19.1%) | Added |
| 4 | Mariner, LLC | 121.8K | $35.1K | +0 (+0.0%) | No change |
| 5 | World Investment Advisors | 104.0K | $30.0K | -96.0K (-48.0%) | Trimmed |
| 6 | Carnegie Investment Counsel | 100.2K | $28.9K | +0 (+0.0%) | No change |
| 7 | BlackRock, Inc. | 65.5K | $18.9K | -5.4K (-7.6%) | Trimmed |
| 8 | UBS Group AG | 62.5K | $18.0K | -33.4K (-34.8%) | Trimmed |
| 9 | Brookwood Investment Group LLC | 49.1K | $14.1K | +0 (+0.0%) | No change |
| 10 | COMMONWEALTH EQUITY SERVICES, LLC | 44.8K | $12.9K | — | New |
| 11 | Sequoia Financial Advisors, LLC | 43.4K | $12.5K | +0 (+0.0%) | No change |
| 12 | Kestra Advisory Services, LLC | 41.1K | $11.8K | +0 (+0.0%) | No change |
| 13 | Newbridge Financial Services Group, Inc. | 41.0K | $11.8K | +37.0K (+925.0%) | Added |
| 14 | Cetera Investment Advisers | 17.1K | $4.9K | +0 (+0.0%) | No change |
| 15 | HighTower Advisors, LLC | 15.7K | $4.5K | +0 (+0.0%) | No change |
| 16 | Radnor Capital Management, LLC | 15.0K | $4.3K | +0 (+0.0%) | No change |
| 17 | Vanguard Global Advisers, LLC | 14.9K | $4.3K | — | New |
| 18 | OPPENHEIMER & CO INC | 10.0K | $2.9K | +0 (+0.0%) | No change |
| 19 | DOCK STREET ASSET MANAGEMENT INC | 10.0K | $2.9K | +0 (+0.0%) | No change |
| 20 | JPMORGAN CHASE & CO | 220 | $67 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once MLSS's latest filing finishes processing.